HighTower Advisors
MNOV icon

HighTower Advisors’s MediciNova MNOV Stock Holding History

HighTower Advisors’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.8K Buy
+10,000
New +$16.5K ﹤0.01% 3797

Other funds holding MNOV

Essex Woodlands Management
Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Focus Partners Advisor Solutions
Focus Partners Advisor Solutions Saint Louis, Missouri $12.4B AUM 18.32% 1-Year Est. Return
Hantz Financial Services
Hantz Financial Services Southfield, Michigan $7.48B AUM 14.09% 1-Year Est. Return

HighTower Advisors's MNOV Position: Q3 2026 in Review

HighTower Advisors opened a new position in MediciNova (MNOV) in Q3 2026: 10,000 shares worth $16.8K. The stake represents ﹤0.01% of the portfolio and ranks #3797 among its holdings.

15 funds tracked by Wall St. Rank hold MNOV as of Q3 2026.

  • HighTower Advisors held 10,000 shares of MediciNova worth $16.8K as of Q3 2026.
  • MediciNova was a new HighTower Advisors position in Q3 2026.
  • MediciNova made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3797 holding.
  • 15 funds tracked by Wall St. Rank held MediciNova as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.